SST Corporation was founded in New York City in 1948, as a brokerage house for heavy and industrial chemical supply. It takes its name from the three founding partners – Fred Schmitz, Arthur Schoenwaldt and Harry Turner. In 1950, the company shifted direction and entered the burgeoning pharmaceutical market, as a supplier of active pharmaceutical ingredients (APIs). During those early days, SST sought out relationships mainly with European-based API manufacturers, and developed its first long-term partnership with Boehringer Mannheim, to distribute Quinine and Quinidine.
Throughout the 1950s, we rapidly expanded our relationships with suppliers in Europe, adding several other major German manufacturers to our network. As the growing pharmaceutical industry continued to flourish, so too did SSTs partnerships, which soon included top API manufacturers in Italy, Finland and Spain. Eventually that list lengthened to include companies in Israel, India, Japan, Korea, China and the United States as well. By the early 1960s, SST was solidly established as a dependable and knowledgeable agency connecting pharmaceutical, API and fine chemical sources worldwide with manufacturers of generic and ethical pharmaceuticals and bulk vitamins in the United States.
As the business grew, it became necessary to construct a larger facility to house the company’s expanded operations. In 1985, SST moved into a brand-new facility in Clifton, New Jersey. In addition to housing the company headquarters, the facility provides a huge, attached warehouse for storage and control of the chemicals required for just-in-time delivery to our customers. One of the most unique aspects of our business is the capability to maintain substantial inventory and ship most of the products we sell directly from our warehouse.
Today, we still represent many of the international suppliers
that partnered with us decades ago. Our business continues
to evolve to parallel new developments in the market and
meet the changing needs of our customers, but our commitment to excellence – and to the relationships that brought us this far – remains the same.